Skin conditions – FAQs
Living with a skin condition often raises many questions, from understanding what is happening in your body to knowing which treatments might help. Our aim is to help you better understand your condition so you can speak with your healthcare professional with more confidence and feel more involved in decisions about your care.
Frequently asked questions
Yes, at Almirall we focus mainly on chronic inflammatory skin diseases such as psoriasis and atopic dermatitis. We focus on these areas to develop targeted treatments that address both symptoms and underlying mechanisms of disease.
Millions of people worldwide live with dermatological disorders affecting daily life. These conditions can range from mild and occasional to severe and persistent, requiring ongoing medical care.
Yes, many skin conditions affect self-esteem, relationships and psychological wellbeing. Visible signs, significant symptoms and persistent discomfort can lead to anxiety, low mood or social withdrawal if not properly managed.
Causes vary and may include genetics, immune response, environmental triggers or infections among others. In many cases, several factors interact, which is why treatment often needs to be tailored to each individual.
Some can be managed effectively, while others may require long-term treatment. Even when a cure is not possible, modern therapies can help reduce signs and symptoms, prevent flare-ups and improve quality of life.
A condition where the immune system overreacts and causes skin inflammation. This can result in redness, swelling, itching or pain and may appear in patches/ plaques in localized or widespread areas of the body.
Most have visible signs, but presentation and severity can vary widely both between individuals and the same patient over time. Some conditions may be subtle or located in covered areas of the body and may be mistaken for or associated with other conditions, which is why a dermatological examination is important.
Yes. Stress, diet, skincare habits, climate, pollution and allergens, among others, can influence both signs and symptoms. Addressing underlying or triggering factors following expert guidance may complement medical treatment.
Almirall supports skin condition research by focusing its R&D on medical dermatology across the full development pathway: deepening understanding of skin diseases, identifying and validating new treatment targets, designing and characterizing potential therapies to ensure they are safe, and then testing them in clinical trials (first in healthy volunteers, then in patients). It also works closely with research institutions, clinicians, and patient associations to identify unmet needs and help ensure new treatments are practical and relevant for the people who will use them.
Yes, conditions like eczema often begin in childhood. Early diagnosis and appropriate management can help reduce signs and symptoms, improve comfort and support healthy development.
Most inflammatory skin disorders are not contagious. However, some skin conditions can indeed be contagious (e.g. infections), so it is important to seek medical advice for an accurate diagnosis.
Yes, signs and symptoms may improve or worsen based on treatment and triggers. Disease patterns can evolve, so regular follow-up with healthcare professionals is essential to adapt management as needed.
How can we help you?
For more information about our products, research, or strategic initiatives, please contact our Investor Relations team or our commercial and medical experts, who are available to assist with your enquiries.